YANLI JIANG1, Pin Yang1, FengXian Fan1, Wanjun Hu1, Jing Zhang1, and Shaoyu Wang2
1Department of Magnetic Resonance, LanZhou University Second Hospital, LanZhou, China, 2MR Scientific Marketing, Siemens Healthineers, Shanghai, China
Synopsis
The aim of this study was using B1 corrected native
T1 value to assess their diagnostic accuracy for staging of liver fibrosis. We found that native T1 values increased
with the level of liver fibrosis, and a
positive correlation was found between liver FibroScan results and the native T1 values. In conclusion,
the B1 corrected native T1 values might be useful for staging of liver
fibrosis.
Introduction and purpose
Traditionally, the staging of liver fibrosis
can be based on biopsy and/or transient elastography. However, to find an
acknowledged noninvasive imaging methods for quantifying liver fibrosis is
still a challenge. There are many studies[1-3] reported to evaluate
the value of gadolinium⁃ethoxybenzyl⁃diethylenetriamine pentaacetic acid enhanced
T1-mapping to assess the staging of liver fibrosis. Meanwhile few study
evaluate the potential of native T1-mapping before.
Our study aimed to evaluate the potential and accuracy of B1
corrected native T1 value in staging of liver fibrosis, and its correlation
with FibroScan results.Materials and Methods
Twenty-nine patients underwent MR examinations on a
1.5T MR scanner (MAGNETOM Aera, Siemens Healthcare, Erlangen, Germany) using a combination of 18-channel body and
12-channel spine matrix coil elements. T1mapping using B1
inhomogeneity–corrected VFA VIBE method was obtained with the following
parameters: TE 2.08ms, TR 4.33 ms, flip angle: 3,15 degrees, FOV: 380 × 332 mm2,
matrix: 156 × 256, slice thickness: 3.5 mm, number of slices: 72, acquisition
time: 19 s. To correct B1 heterogeneity, a B1 mapping pulse sequence was
implemented to acquire a B1 field map of the entire liver using the stimulated
echo/spin echo method before VFA T1 mapping. The native T1 values were measured
on the T1 image parameter maps on a Syngo.Vsia system (Siemens
Healthineers).The histopathologic diagnosis of liver fibrosis (S) and necroinflammatory activity (G) was confirmed by liver biopsy. Twenty-seven patients of them
underwent transient elastography examination (TE), from them we get fibroscan to evaluate the elasticity of liver tissue. Figure 1 showed the example of placing region of interest (ROI).Results
The mean values and standard deviation(SD) of
native T1 values of the different staging of liver fibrosis and necroinflammatory
activity is showed in Table 1. The native T1 values were significantly higher
in the severe fibrosis (≥S3) than that of mild fibrosis (≤S2),P=0.013, Which suggest that the native T1 values may be helpful for staging
of liver fibrosis. Meanwhile, the native T1 values were higher in the severe
necroinflammatory activity (≥G3) than that of mild activity (≤G2),but the difference was not statistically significant, P=0.51.
The correlation of native T1 values with FibroScan
was showed in figure 2. There was a significant correlation between them,
r=0.398, P=0.04. Discussion and conclusion
Our study showed that native T1 values can be
useful in staging of liver fibrosis. The correlation of native T1 values with
FibroScan was positive, r=0.398, P=0.04. The result was the same as in previous
studies [4,5], that’s because the collagen deposition can prolong
the T1 values. Some studies [6,7] indicated that inflammation, iron
concentration, and steatosis could also influence the measurement, but in our
study, the native T1 values in different stage of necroinflammatory activity
has no significant difference. That may prove that the collagen deposition
place an important role in the changing of T1 values. While multicenter trials
with larger sample sizes are needed to confirm our findings. In addition, it is
a simple approach for liver fibrosis quantification that dose not depend on intravenous
contrast injection. In conclusion, our results show that native T1 values had
potential value for staging of liver fibrosis.Acknowledgements
This article is supported by the Lanzhou Chengguan District Science and Technology Plan Project (No. 2019SHFZ0037)References
1. Sheng RF, Wang HQ, Yang L, et al. Assessment of
liver fibrosis using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance.
Digestive and Liver Disease 2017: 49: 789-795
2. Jiang Y, Qiu WJ, Zhou ZP. The application of
Gd-EOB-DTPA-enhanced MRI T1 mapping and its research progresses in hepatic
diseases. Int J Med Radiol 2019: 42: 208-211
3. Qiu T, Zhang ZQ, Chen WB, et al. MRI in the
quantitative evaluation of hepatic fibrosis in patients with hepatitis B. Chin
J Radiol, 2019:53: 1081-1085
4. Ramachandran P, Serai SD, Veldtman GR et al,
Assessment of liver T1 mapping in fontan patients and its correlation with
magnetic resonance elastography-derived liver stiffness. Abdom Radiol 2019
44(7):2403–2408
5. Li JN, Liu HH, Zhang CY, et al. Native T1 mapping
compared to ultrasound elastography for staging and monitoring liver fibrosis:
an animal study of repeatability, reproducibility, and accuracy. European
Radiology 2020 30(1): 337-345
6. Dekkers IA, Lamb HJ (2018) Clinical application and
technical considerations of T1 & T2(*) mapping in cardiac, liver, and renal
imaging. Br J Radiol 91:20170825
7. Chow AM, Gao DS, Fan SJ et al. Measurement of liver
T1 and T2 relaxation times in an experimental mouse model of liver fibrosis. J
Magn Reson Imaging 2012 36(1): 152-158